>سوق تشخيص صحة المرأة في أوروبا، حسب التطبيق (اختبار سرطان الثدي، اختبار سرطان عنق الرحم، اختبار الحمل والخصوبة، اختبار سرطان المبيض، اختبار الأمراض المعدية ، اختبارات الموجات فوق الصوتية، اختبار الأمراض المنقولة جنسيا، وغيرها)، الاختبارات (الخزعات، اختبارات سرطان الثدي الأخرى، اختبار الحمل والخصوبة، الاختبارات المعملية، اختبار الحمل ومجموعات التنبؤ بالإباضة، أجهزة مراقبة الخصوبة، الفحص الجيني قبل الولادة واختبار الناقل، اختبار التليف الكيسي، اختبار متلازمة داون ومتلازمة إدواردز، اختبار TORCH، اختبارات الأمراض الوراثية قبل الولادة الأخرى، اختبار الأمراض المعدية، اختبار المكورات العنقودية الذهبية المقاومة للميثيسيلين، اختبار التهاب المسالك البولية، اختبار التهاب الكبد)، وحسب المستخدم النهائي (مراكز التشخيص والتصوير والمستشفيات والعيادات والرعاية المنزلية) - اتجاهات الصناعة والتوقعات حتى عام 2029
تحليل السوق والحجم
وفقًا لمنظمة الصحة العالمية، يعيش أكثر من 470 مليون امرأة في المنطقة الأوروبية، وهو ما يمثل أكثر من نصف إجمالي السكان. يتطلب فهم التغيرات الديموغرافية والوبائية التي تحدث في هذه المنطقة المتنوعة، مثل الشيخوخة والهجرة، فهم صحة المرأة. علاوة على ذلك، بلغ الناتج المحلي الإجمالي لمنطقة الاتحاد الأوروبي حوالي 18.8 تريليون دولار أمريكي في عام 2018، وفقًا للبنك الدولي، والإنفاق الصحي هو ثاني أكبر بند من الإنفاق الحكومي العام بعد إنفاق الضمان الاجتماعي. بلغ إجمالي الإنفاق الصحي من قبل الحكومة الفيدرالية 9.6 في المائة من الناتج المحلي الإجمالي. سيؤدي هذا إلى زيادة البنية التحتية للرعاية الصحية وعدد المختبرات السريرية ومرافق التشخيص في أوروبا، مما يعزز سوق تشخيص صحة المرأة في العام المقبل.
تحلل شركة Data Bridge Market Research أن سوق تشخيص صحة المرأة الذي بلغ 26.48 مليار دولار أمريكي في عام 2021، سيرتفع إلى 41.88 مليار دولار أمريكي بحلول عام 2029، ومن المتوقع أن يخضع لمعدل نمو سنوي مركب بنسبة 5.9٪ خلال الفترة المتوقعة 2022-2029. يتضمن تقرير السوق الذي أعده فريق Data Bridge Market Research تحليلًا متعمقًا من الخبراء، وعلم الأوبئة لدى المرضى، وتحليل خط الأنابيب، وتحليل الأسعار، والإطار التنظيمي.
تعريف السوق
تشير صحة المرأة إلى تشخيص وعلاج الأمراض التي قد تؤثر على صحة المرأة الجسدية والعقلية. وتشمل صحة المرأة وسائل منع الحمل، والأمراض المنقولة جنسياً، واضطرابات أمراض النساء، وسرطان الثدي، وسرطان المبيض، وسرطانات أخرى تصيب النساء، وانقطاع الطمث، والعلاج الهرموني، وهشاشة العظام، والحمل والولادة، والصحة الجنسية، وأمراض القلب لدى النساء، والأمراض الحميدة التي تؤثر على وظيفة الأعضاء التناسلية الأنثوية.
نطاق التقرير وتقسيم السوق
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2022 إلى 2029 |
|
سنة الأساس |
2021 |
|
سنوات تاريخية |
2020 (قابلة للتخصيص حتى 2019 - 2014) |
|
وحدات كمية |
الإيرادات بالمليارات من الدولارات الأمريكية، الأحجام بالوحدات، التسعير بالدولار الأمريكي |
|
القطاعات المغطاة |
التطبيق (اختبار سرطان الثدي، اختبار سرطان عنق الرحم، اختبار الحمل والخصوبة، اختبار سرطان المبيض، اختبار الأمراض المعدية، اختبارات الموجات فوق الصوتية، اختبار الأمراض المنقولة جنسياً، وغيرها)، ومن قبل المستخدم النهائي (مراكز التشخيص والتصوير، والمستشفيات والعيادات، والرعاية المنزلية) |
|
الدول المغطاة |
الولايات المتحدة وكندا والمكسيك في أمريكا الشمالية وألمانيا وفرنسا والمملكة المتحدة وهولندا وسويسرا وبلجيكا وروسيا وإيطاليا وإسبانيا وتركيا وبقية دول أوروبا في أوروبا |
|
الجهات الفاعلة في السوق المشمولة |
Siemens (ألمانيا)، Hologic, Inc. (MA)، Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (الصين)، Abbott (الولايات المتحدة)، BD (نيوجيرسي)، F. Hoffmann-La Roche Ltd (سويسرا)، Thermo Fisher Scientific Inc. (الولايات المتحدة)، Koninklijke Philips NV (هولندا)، NeuroLogica Corp. (الولايات المتحدة)، Shimadzu Medical (الهند) pvt. Ltd. (اليابان)، GENERAL ELECTRIC (الولايات المتحدة)، Quest Diagnostics Incorporated (الولايات المتحدة)، Sysmex India Pvt. Ltd. (اليابان)، Hitachi, Ltd. (اليابان)، Canon Inc. (اليابان)، FUJIFILM Holdings Corporation (المملكة المتحدة) |
|
فرص السوق |
|
ديناميكيات سوق تشخيص صحة المرأة
السائقين
- زيادة حالات الإصابة بالاضطرابات المزمنة والمرتبطة بأسلوب الحياة
العدد المتزايد من مراكز التصوير والتشخيص، فضلاً عن الاستخدام الموسع لفحوصات الرعاية المباشرة والتشخيص السريع. ومع ارتفاع معدل انتشار هشاشة العظام وسرطان المبيض وسرطان الثدي وسرطان عنق الرحم، فإن سوق تشخيص صحة المرأة ينمو. سرطان الثدي هو السرطان الأكثر شيوعًا بين النساء وثاني أكثر أنواع السرطان شيوعًا في العالم. في عام 2018، تم الإبلاغ عن ما يقرب من 2 مليون حالة جديدة.
- زيادة في معدل الموافقة على اختبارات التشخيص في نقطة الرعاية
ومن المتوقع أن ينمو السوق مع ارتفاع عدد أجهزة التشخيص والتصوير المباعة في جميع أنحاء العالم. ومع ذلك، من المتوقع أن يؤدي ارتفاع الطلب على تطوير أجهزة التشخيص المصغرة، فضلاً عن زيادة البنية التحتية للرعاية الصحية ومبادرات التسويق الجديدة من قبل البائعين الرئيسيين في البلدان الناشئة، إلى توسع السوق خلال الفترة المتوقعة 2022-2029.
- تزايد انتشار هشاشة العظام وسرطان المبيض وسرطان الثدي وسرطان عنق الرحم
سرطان الثدي هو السرطان الأكثر شيوعًا بين النساء وثاني أكثر أنواع السرطان شيوعًا في العالم. وفقًا لـ Globocan 2020، سيتم تشخيص 2،261،419 حالة جديدة من سرطان الثدي في عام 2020. أدى العدد المتزايد من الحالات إلى زيادة مبيعات أدوات الاختبار للاستخدام المنزلي، ومن المتوقع أن يؤدي ذلك إلى زيادة نمو إيرادات السوق طوال فترة التوقعات. ومن المتوقع أن يؤدي القبول المتزايد لاختبارات التشخيص في نقطة الرعاية وزيادة عدد معدات التشخيص والتصوير المتاحة عالميًا إلى دفع السوق إلى الأمام.
فرص
Breast cancer's rising prevalence, greater research and development spending, and improvements in cancer diagnostics are all expected to accelerate segmental expansion. According to Globocan, roughly 2.26 million new instances of breast cancer were diagnosed in females worldwide in 2020, accounting for around 11.7 percent of all cancer cases. As the patient pool for breast cancer develops, demand for diagnostics is projected to climb even quicker. Product launches are another major factor in the market's expansion.
Restraints/Challenges
Patients' resistance to early screening, which needs considerable expenditures for detection, the possibility of over-diagnosis and overtreatment, and the fact that MRI scans are accurate yet time consuming and costly for patients are all problems that the women's health diagnostic market faces.
Diagnostic tests for women's health are costly, which is a significant barrier to market entry. The women's health diagnostic sector has considerable challenges due to a lack of information about various illnesses and diagnostic methodologies. Low-income companies and emerging economies are addressing market constraints in women's health diagnostics.
This women’s health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Women’s Health Diagnostics Market
Due to capital market and global economy uncertainty, limited transit options and travel restrictions created impediments to international trade and transportation during the COVID-19 pandemic, affecting the supply chain for women's health diagnostics and temporarily lowering demand. The advancement of this industry is impeded by unfavourable changes in rules and laws. According to major regulatory organisations, COVID-19 infection is more common in breast cancer patients than in healthy people. Screening, surgical operations, and diagnostic screenings at hospitals and breast cancer clinics have all been postponed or severely curtailed as a result.
Recent Development
- Roche announced in May 2019 that the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer would be available. This would contribute to the company's product line being expanded.
Europe Women’s Health Diagnostics Market Scope
يتم تقسيم سوق تشخيص صحة المرأة على أساس الاختبار والتطبيق والمستخدم النهائي. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات النمو الضئيلة في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.
طلب
- اختبار هشاشة العظام
- قياس كثافة العظام
- فحوصات الدم المختبرية
- اختبار OVC
- اختبارات علامة الورم في OVC
- اختبارات التصوير التشخيصي لـ OVC
- اختبارات OVC الأخرى
- اختبار سرطان عنق الرحم
- مسحات عنق الرحم
- اختبار فيروس الورم الحليمي البشري
- اختبار سرطان الثدي
- تصوير الثدي بالأشعة السينية
الاختبارات
- الخزعات
- اختبارات سرطان الثدي الأخرى
- اختبار الحمل والخصوبة
- الاختبارات المعملية
- أدوات اختبار الحمل وتوقع التبويض
- أجهزة مراقبة الخصوبة
- الفحص الجيني قبل الولادة واختبار الناقل
- اختبار التليف الكيسي
- اختبار متلازمة داون ومتلازمة إدواردز
- اختبار الشعلة
- اختبارات الأمراض الوراثية الأخرى قبل الولادة
- اختبار الأمراض المعدية
- اختبار المكورات العنقودية الذهبية المقاومة للميثيسيلين
- اختبار التهاب المسالك البولية
- اختبار التهاب الكبد
- اختبار السل
- اختبارات الأمراض المعدية الأخرى
- اختبار الأمراض المنقولة جنسيا
- اختبار التصوير المقطعي المحوسب/الأنف المعدي
- اختبار فيروس نقص المناعة البشرية
- اختبارات الأمراض المنقولة جنسيا الأخرى
- اختبارات الموجات فوق الصوتية
- تصوير الثدي
- تصوير أمراض النساء والتوليد
المستخدم النهائي
- المستشفيات والعيادات
- مراكز التشخيص والتصوير
- إعدادات الرعاية المنزلية
تحليل/رؤى إقليمية لسوق تشخيصات صحة المرأة
يتم تحليل سوق تشخيص صحة المرأة وتوفير رؤى حجم السوق والاتجاهات حسب البلد والاختبار والتطبيق والمستخدم النهائي كما هو مذكور أعلاه.
الدول المشمولة في تقرير سوق تشخيص صحة المرأة هي الولايات المتحدة وكندا والمكسيك في أمريكا الشمالية وألمانيا وفرنسا والمملكة المتحدة وهولندا وسويسرا وبلجيكا وروسيا وإيطاليا وإسبانيا وتركيا وبقية أوروبا في أوروبا والصين واليابان والهند وكوريا الجنوبية وسنغافورة وماليزيا وأستراليا وتايلاند وإندونيسيا والفلبين وبقية دول آسيا والمحيط الهادئ (APAC) في منطقة آسيا والمحيط الهادئ (APAC) والمملكة العربية السعودية والإمارات العربية المتحدة وجنوب إفريقيا ومصر وإسرائيل وبقية دول الشرق الأوسط وأفريقيا (MEA) كجزء من الشرق الأوسط وأفريقيا (MEA) والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية كجزء من أمريكا الجنوبية.
في ظل الانتشار الواسع للسرطان بين النساء، وارتفاع معدل الاضطرابات المرتبطة بأسلوب الحياة، والاعتماد الكبير على المنتجات المتقدمة من الناحية التكنولوجية، وإطلاق المنتجات، والمبادرات الحكومية، من المتوقع أن ينمو سوق تشخيص صحة المرأة في أمريكا الشمالية وأوروبا بشكل مطرد.
بفضل زيادة الحملات المتعلقة بقضايا صحة المرأة والتوعية بالأمراض، نجحت منطقة آسيا والمحيط الهادئ في تحسين وضع الرعاية الصحية لديها وبرزت كمشاركة متزايدة في سوق تشخيص صحة المرأة.
يقدم قسم الدولة في التقرير أيضًا عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. أيضًا، يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية وطرق التجارة أثناء تقديم تحليل تنبؤي لبيانات الدولة.
نمو البنية التحتية للرعاية الصحية والقاعدة المركبة واختراق التكنولوجيا الجديدة
كما يوفر لك سوق تشخيص صحة المرأة تحليلاً تفصيلياً للسوق لكل نمو في الإنفاق الصحي على المعدات الرأسمالية في كل دولة، والقاعدة المثبتة لأنواع مختلفة من المنتجات لسوق تشخيص صحة المرأة، وتأثير التكنولوجيا باستخدام منحنيات خط الحياة والتغييرات في سيناريوهات التنظيم الصحي وتأثيرها على سوق تشخيص صحة المرأة. البيانات متاحة للفترة التاريخية 2010-2020.
تحليل المنافسة وحصة سوق تشخيصات صحة المرأة
يوفر المشهد التنافسي لسوق تشخيصات صحة المرأة تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق تشخيصات صحة المرأة.
بعض اللاعبين الرئيسيين العاملين في سوق تشخيص صحة المرأة هم:
- سيمنز (ألمانيا)
- شركة هولوجيك (ماساتشوستس)
- شركة شنتشن ميندراي للإلكترونيات الطبية الحيوية المحدودة (الصين)
- أبوت (الولايات المتحدة)
- BD (نيوجيرسي)
- شركة ف. هوفمان-لا روش المحدودة (سويسرا)
- شركة ثيرمو فيشر العلمية (الولايات المتحدة)
- كونينكليكي فيليبس إن في (هولندا)
- شركة نيورولوجيكا (الولايات المتحدة الأمريكية)
- شركة شيمادزو الطبية (الهند) المحدودة (اليابان)
- جنرال الكتريك (الولايات المتحدة)
- شركة كويست دياجنوستيكس المحدودة (الولايات المتحدة)
- سيسمكس الهند الجندي. المحدودة (اليابان)
- شركة هيتاشي المحدودة (اليابان)
- شركة كانون (اليابان)
- شركة فوجي فيلم القابضة (المملكة المتحدة)
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING GERIATRIC FEMALE POPULATION
3.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES
3.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES
3.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES
3.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT
3.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES
3.4 CHALLENGES
3.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S.
3.4.2 PRICING PRESSURE
3.4.3 INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES
6.1 OVERVIEW
6.2 IMAGING AND MONITORING SYSTEMS
6.2.1 MAMMOGRAPHY SYSTEMS
6.2.1.1 DEVICES
6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS
6.2.1.1.2 BREAST TOMOSYNTHESIS
6.2.1.1.3 ANALOG MAMMOGRAPHY SYSTEMS
6.2.1.2 APPLICATIONS
6.2.1.2.1 BREAST LUMPS OR TUMORS
6.2.1.2.2 BREAST CANCER
6.2.1.2.3 OTHERS
6.2.2 ULTRASOUND IMAGING SYSTEMS
6.2.2.1 DEVICES
6.2.2.1.1 OB/GYN ULTRASOUND
6.2.2.1.2 BREAST ULTRASOUND
6.2.2.2 APPLICATIONS
6.2.2.2.1 PREGNANCY SCAN
6.2.2.2.1.1 FETAL DEVELOPMENT
6.2.2.2.1.2 FETAL ABNORMALITIES
6.2.2.2.1.3 OTHERS
6.2.2.2.2 PELVIC SCAN
6.2.2.2.2.1 ABNORMAL PERIODS
6.2.2.2.2.2 CYSTS
6.2.2.2.2.3 FIBROIDS
6.2.2.2.2.4 OTHERS
6.2.2.2.3 ABDOMINAL SCAN
6.2.2.2.4 OTHERS
6.2.2.2.4.1 BREAST SCANS
6.2.2.2.4.2 MUSCULOSKELETAL SCANS
6.2.2.2.4.3 INTERNAL STRUCTURES
6.2.3 MRI SYSTEMS
6.2.3.1 APPLICATIONS
6.2.3.1.1 BREAST SCAN
6.2.3.1.2 ABDOMEN SCAN
6.2.3.1.3 JOINTS SCAN
6.2.3.1.4 SPINAL CORD SCAN
6.2.3.1.5 CARDIAC SCAN
6.2.3.1.6 BLOOD VESSELS SCAN
6.2.3.1.7 OTHERS
6.2.4 FERTILITY MONITORS
6.2.4.1 APPLICATIONS
6.2.4.1.1 OVULATION
6.2.4.1.2 INFERTILITY
6.2.4.1.3 PREGNANCY
6.2.4.1.4 HORMONAL IMBALANCE
6.2.4.1.5 OTHERS
6.2.5 BONE DENSITOMETER
6.2.5.1 APPLICATIONS
6.2.5.1.1 OSTEOPOROSIS
6.2.5.1.2 BONE-RELATED PROBLEMS
6.2.5.1.3 RHEUMATOID ARTHRITIS
6.2.6 NUCLEAR IMAGING SYSTEMS
6.2.6.1 APPLICATIONS
6.2.6.1.1 OSTEOARTHRITIS
6.2.6.1.2 HEART DISEASE
6.2.6.1.3 UROLOGICAL PROBLEMS
6.2.6.1.4 GYNECOLOGICAL CANCERS
6.2.6.1.5 MULTIPLE SCLEROSIS
6.2.6.1.6 ALZHEIMER’S DISEASE
6.2.6.1.7 THYROID DISEASE
6.2.6.1.8 SEXUALLY TRANSMITTED INFECTIONS
6.2.6.1.9 STROKE
6.2.6.1.10 POST-TRAUMATIC STRESS DISORDER (PTSD)
6.2.6.1.11 LUPUS
6.2.6.1.12 OTHERS
6.2.7 OTHERS
6.3 BIOPSY DEVICES
6.3.1 BIOPSY FOR CANCER
6.3.1.1 BREAST CANCER
6.3.1.2 CERVICAL CANCER
6.3.1.3 OVARIAN CANCER
6.3.1.4 OTHERS
6.3.2 BREAST LUMPS BIOPSY
6.3.3 BLOOD BIOPSY
6.3.3.1 CANCEROUS
6.3.3.2 NON-CANCEROUS
6.3.4 LYMPH NODES BIOPSY
6.3.5 THYROID BIOPSY
6.3.6 SKIN BIOPSY
6.3.7 OTHERS
6.4 REAGENTS AND KITS
6.4.1 PREGNANCY AND FERTILITY TESTING KITS
6.4.1.1 PREGNANCY
6.4.1.2 OVULATION
6.4.1.3 OTHERS
6.4.2 BLOOD TEST TYPE KIT
6.4.2.1 OSTEOPOROSIS
6.4.2.2 BLOOD CHEMISTRY & BLOOD CELL COUNT
6.4.2.3 OTHERS
6.4.3 HEPATITIS TESTING KIT
6.4.4 TUMOR MARKER ELISA TEST KIT
6.4.5 STD TEST KITS
6.4.5.1 HIV TESTING
6.4.5.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING
6.4.5.3 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
6.4.5.4 OTHERS
6.4.6 PAP SMEAR TEST KIT
6.4.7 MRSA TESTING KITS
6.4.8 HORMONE MARKERS ELISA KITS
6.4.9 TUBERCULOSIS TEST KIT
6.4.10 OTHERS
6.5 BIOMARKERS
6.5.1 ONCOLOGY
6.5.1.1 BREAST CANCER
6.5.1.2 CERVICAL CANCER
6.5.1.3 OVARIAN CANCER
6.5.1.4 OTHERS
6.5.2 PREGNANCY COMPLICATIONS
6.5.3 INFECTIOUS DISEASES
6.5.4 CARDIOVASCULAR DISEASES
6.5.5 OTHERS
6.6 OTHERS
7 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DIAGNOSTIC AND IMAGING CENTERS
7.4 CLINICS
7.5 HOME CARE SETTING
8 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 EUROPE
8.1.1 GERMANY
8.1.2 FRANCE
8.1.3 U.K.
8.1.4 ITALY
8.1.5 SPAIN
8.1.6 RUSSIA
8.1.7 SWITZERLAND
8.1.8 NETHERLANDS
8.1.9 BELGIUM
8.1.10 TURKEY
8.1.11 REST OF EUROPE
9 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: EUROPE
10 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILE
13.1 HOLOGIC INC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 SIEMENS
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 GENERAL ELECTRIC
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
13.4 KONINKLIJKE PHILIPS N.V.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 HITACHI, LTD.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 FUJIFILM HOLDINGS CORPORATION
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 COMPANY SHARE ANALYSIS
13.6.4 PRODUCT PORTFOLIO
13.6.5 RECENT DEVELOPMENTS
13.7 ABBOTT
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 BD
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BIOMERIEUX SA
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 BIOMERIEUX SA
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 CANON INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 CARDINAL HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 CARESTREAM HEALTH
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENT
13.14 COOK
13.14.1 COMPANY SNAPSHOT
13.14.2 DIVISION PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
13.15 DANAHER
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 F. HOFFMANN-LA ROCHE LTD.
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 MEDGYN PRODUCTS, INC
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENT
13.18 NEUROLOGICA CORP.
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 PERKINELMER INC.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 SHIMADZU CORPORATION
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPEMNT
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENT
13.23 THERMO FISHER SCIENTIFIC INC.
13.23.1 COMPANY SNAPSHOT
13.23.2 REVENUE ANALYSIS
13.23.3 PRODUCT PORTFOLIO
13.23.4 RECENT DEVELOPMENTS
13.24 URIT MEDICAL ELECTRONIC CO., LTD
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENT
14 CONCLUSION
15 SWOT ANALYSIS AND DBMR ANALYSIS
15.1 SWOT ANALYSIS
15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)
TABLE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 3 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 4 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 5 EUROPE MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)
TABLE 6 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 7 EUROPE ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 8 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 9 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 10 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 11 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 12 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 13 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 14 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 15 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 16 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 18 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 19 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 20 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 EUROPE REAGENTS AND KITS IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 22 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 23 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 24 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 25 EUROPE BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 27 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 28 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 EUROPE HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 EUROPE DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 EUROPE CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 EUROPE HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 35 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 36 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 37 EUROPE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 38 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 39 EUROPE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 40 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 41 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 42 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 43 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 44 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 45 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 46 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 47 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 48 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 49 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 50 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 51 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 52 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 53 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 54 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 55 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 56 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 57 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 59 GERMANY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 60 GERMANY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 61 GERMANY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 62 GERMANY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 63 GERMANY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 64 GERMANY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 65 GERMANY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 66 GERMANY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 67 GERMANY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 68 GERMANY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 69 GERMANY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 70 GERMANY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 71 GERMANY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 72 GERMANY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 73 GERMANY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 74 GERMANY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 75 GERMANY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 76 GERMANY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 77 GERMANY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 78 GERMANY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 79 GERMANY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 80 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 82 FRANCE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 83 FRANCE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 84 FRANCE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 85 FRANCE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 86 FRANCE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 87 FRANCE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 88 FRANCE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 89 FRANCE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 90 FRANCE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 91 FRANCE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 92 FRANCE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 93 FRANCE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 94 FRANCE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 95 FRANCE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 96 FRANCE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 97 FRANCE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 98 FRANCE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 99 FRANCE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 100 FRANCE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 101 FRANCE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 102 FRANCE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 103 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 104 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 105 U.K. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 106 U.K. MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 107 U.K. APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 108 U.K. ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 109 U.K. APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 110 U.K. PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 111 U.K. PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 112 U.K. OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 113 U.K. APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 114 U.K. APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 115 U.K. APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 116 U.K. BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 117 U.K. BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 118 U.K. BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 119 U.K. BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 120 U.K. BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 121 U.K. ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 122 U.K. REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 123 U.K. PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 124 U.K. BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 125 U.K. STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 126 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 127 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 128 ITALY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 129 ITALY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 130 ITALY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 131 ITALY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 132 ITALY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 133 ITALY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 134 ITALY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 135 ITALY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 136 ITALY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 137 ITALY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 138 ITALY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 139 ITALY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 140 ITALY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 141 ITALY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 142 ITALY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 143 ITALY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 144 ITALY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 145 ITALY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 146 ITALY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 147 ITALY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 148 ITALY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 149 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 150 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 151 SPAIN IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 152 SPAIN MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 153 SPAIN APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 154 SPAIN ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 155 SPAIN APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 156 SPAIN PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 157 SPAIN PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 158 SPAIN OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 159 SPAIN APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 160 SPAIN APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 161 SPAIN APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 162 SPAIN BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 163 SPAIN BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 164 SPAIN BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 165 SPAIN BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 166 SPAIN BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 167 SPAIN ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 168 SPAIN REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 169 SPAIN PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 170 SPAIN BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 171 SPAIN STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 172 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 174 RUSSIA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 175 RUSSIA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 176 RUSSIA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 177 RUSSIA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 178 RUSSIA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 179 RUSSIA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 180 RUSSIA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 181 RUSSIA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 182 RUSSIA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 183 RUSSIA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 184 RUSSIA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 185 RUSSIA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 186 RUSSIA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 187 RUSSIA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 188 RUSSIA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 189 RUSSIA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 190 RUSSIA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 191 RUSSIA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 192 RUSSIA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 193 RUSSIA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 194 RUSSIA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 195 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 196 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 197 SWITZERLAND IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 198 SWITZERLAND MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 199 SWITZERLAND APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 200 SWITZERLAND ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 201 SWITZERLAND APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 202 SWITZERLAND PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 203 SWITZERLAND PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 204 SWITZERLAND OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 205 SWITZERLAND APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 206 SWITZERLAND APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 207 SWITZERLAND APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 208 SWITZERLAND BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 209 SWITZERLAND BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 210 SWITZERLAND BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 211 SWITZERLAND BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 212 SWITZERLAND BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 213 SWITZERLAND ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 214 SWITZERLAND REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 215 SWITZERLAND PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 216 SWITZERLAND BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 217 SWITZERLAND STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 218 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 219 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 220 NETHERLANDS IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 221 NETHERLANDS MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 222 NETHERLANDS APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 223 NETHERLANDS ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 224 NETHERLANDS APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 225 NETHERLANDS PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 226 NETHERLANDS PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 227 NETHERLANDS OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 228 NETHERLANDS APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 229 NETHERLANDS APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 230 NETHERLANDS APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 231 NETHERLANDS BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 232 NETHERLANDS BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 233 NETHERLANDS BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 234 NETHERLANDS BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 235 NETHERLANDS BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 236 NETHERLANDS ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 237 NETHERLANDS REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 238 NETHERLANDS PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 239 NETHERLANDS BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 240 NETHERLANDS STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 241 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 242 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 243 BELGIUM IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 244 BELGIUM MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 245 BELGIUM APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 246 BELGIUM ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 247 BELGIUM APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 248 BELGIUM PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 249 BELGIUM PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 250 BELGIUM OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 251 BELGIUM APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 252 BELGIUM APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 253 BELGIUM APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 254 BELGIUM BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 255 BELGIUM BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 256 BELGIUM BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 257 BELGIUM BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 258 BELGIUM BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 259 BELGIUM ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 260 BELGIUM REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 261 BELGIUM PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 262 BELGIUM BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 263 BELGIUM STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 264 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION
TABLE 265 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 266 TURKEY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 267 TURKEY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 268 TURKEY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 269 TURKEY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 270 TURKEY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 271 TURKEY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 272 TURKEY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 273 TURKEY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 274 TURKEY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 275 TURKEY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 276 TURKEY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 277 TURKEY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 278 TURKEY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 279 TURKEY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 280 TURKEY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 281 TURKEY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)\
TABLE 282 TURKEY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 283 TURKEY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 284 TURKEY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 285 TURKEY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 286 TURKEY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 287 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 288 REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
List of Figure
FIGURE 1 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DATA VALIDATION MODEL
FIGURE 3 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: EUROPE VS REGIONAL ANALYSIS
FIGURE 5 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 8 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
FIGURE 12 PERCENT DISTRIBUTION OF THE 10 LEADING CAUSES OF DEATH IN WOMEN: UNITED STATES, 2017
FIGURE 13 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 14 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES AND INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES ARE EXPECTED TO DRIVE THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 IMAGING AND MONTORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 16 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES, 2018
FIGURE 17 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY END USER, 2018
FIGURE 18 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SNAPSHOT (2018)
FIGURE 19 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018)
FIGURE 20 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 21 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 22 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES (2019-2026)
FIGURE 23 EUROPE BIOPSY DEVISE IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 24 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 25 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 26 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
